Abstract
The invention provides small interfering RNA (siRNA) and their carriers that could treat asthma in mammalian through inhibiting acidic mammalian chitinase (AMCase) gene expression. The invention further provides a composition comprising siRNA of the present invention and a carrier. The invention also provides a method for treating asthma of a subject.
| Translated title of the contribution | DEVELOPMENT OF ASTHMA THERAPY WITH rAAV-mediated AMCase shRNA |
|---|---|
| Original language | Chinese (Traditional) |
| Patent number | I378800 |
| IPC | A61K 48/00(2006.01); C12N 15/63(2006.01); C12N 15/861(2006.01); A61P 11/06(2006.01) |
| State | Published - 11 12 2012 |
Bibliographical note
公開公告號: I378800Announcement ID: I378800
Fingerprint
Dive into the research topics of 'DEVELOPMENT OF ASTHMA THERAPY WITH rAAV-mediated AMCase shRNA'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver